Biology Reference
In-Depth Information
Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C (2005) Angiotensin II increases
phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which
angiotensin II antagonizes cGMP signaling. J Mol Cell Cardiol 38:175-184
Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C (2001)
Upregulation of phosphodiesterase 1A1 expression is associated with the development of
nitrate tolerance. Circulation 104:2338-2343
Klinger JR, Warburton R, Carino GP, Murray J, Murphy C, Napier M, Harrington EO (2006)
Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmo-
nary microvascular endothelial cells. Exp Cell Res 312:401-410
Koga S, Morris S, Ogawa S, Liao H, Bilezikian JP, Chen G, Thompson WJ, Ashikaga T,
Brett J, Stern DM et al (1995) TNF modulates endothelial properties by decreasing cAMP.
Am J Physiol 268:C1104-C1113
Komarova Y, Malik AB (2010) Regulation of endothelial permeability via paracellular and
transcellular transport pathways. Annu Rev Physiol 72:463-493
Komarova YA, Mehta D, Malik AB (2007) Dual regulation of endothelial junctional permeability.
Sci STKE 2007:re8
Kooistra MR, Corada M, Dejana E, Bos JL (2005) Epac1 regulates integrity of endothelial cell
junctions through VE-cadherin. FEBS Lett 579:4966-4972
Lang P, Gesbert F, Delespine-Carmagnat M, Stancou R, Pouchelet M, Bertoglio J (1996) Protein
kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic
AMP in cytotoxic lymphocytes. EMBO J 15:510-519
Langeler EG, van Hinsbergh VW (1991) Norepinephrine and iloprost improve barrier function of
human endothelial cell monolayers: role of cAMP. Am J Physiol 260:C1052-C1059
Leemhuis J, Boutillier S, Schmidt G, Meyer DK (2002) The protein kinase A inhibitor H89 acts on
cell morphology by inhibiting Rho kinase. J Pharmacol Exp Ther 300:1000-1007
Leroy MJ, Degerman E, Taira M, Murata T, Wang LH, Movsesian MA, Meacci E, Manganiello
VC (1996) Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide
phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts
and Sf9 insect cells. Biochemistry 35:10194-10202
Li L, Yee C, Beavo JA (1999) CD3- and CD28-dependent induction of PDE7 required for T cell
activation. Science 283:848-851
Liu SM, Sundqvist T (1997) Nitric oxide and cGMP regulate endothelial permeability and F-actin
distribution in hydrogen peroxide-treated endothelial cells. Exp Cell Res 235:238-244
Lorenowicz MJ, Fernandez-Borja M, Kooistra MR, Bos JL, Hordijk PL (2008) PKA and Epac1
regulate endothelial integrity and migration through parallel and independent pathways.
Eur J Cell Biol 87:779-792
Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol
Rev 86:279-367
Michel CC, Curry FE (1999) Microvascular permeability. Physiol Rev 79:703-761
Miro X, Casacuberta JM, Gutierrez-Lopez MD, de Landazuri MO, Puigdomenech P (2000) Phos-
phodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-alpha(1).
Biochem Biophys Res Commun 274:415-421
Moldobaeva A, Welsh-Servinsky LE, Shimoda LA, Stephens RS, Verin AD, Tuder RM, Pearse
DB (2006) Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary
artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 290:L919-L930
Moore TM, Chetham PM, Kelly JJ, Stevens T (1998) Signal transduction and regulation of lung
endothelial cell permeability. Interaction between calcium and cAMP. Am J Physiol 275:
L203-L222
Murray AJ (2008) Pharmacological PKA inhibition: all may not be what it seems. Sci Signal 1:re4
Netherton SJ, Maurice DH (2005) Vascular endothelial cell cyclic nucleotide phosphodiesterases
and regulated cell migration: implications in angiogenesis. Mol Pharmacol 67:263-272
Ozaki H, Hla T, Lee MJ (2003) Sphingosine-1-phosphate signaling in endothelial activation.
J Atheroscler Thromb 10:125-131
